William N. William

11.1k citations

109 papers · 4.0k indexed · 1 hit paper · h-index 33

Impact in

Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies
Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies

Papers in

Otorhinolaryngology 37
- Head and Neck Cancer Studies 37
Oncology 61
- Cancer Immunotherapy and Biomarkers 25
- Lung Cancer Research Studies 15

Co-authors: J. Jack Lee Edward S. Kim John V. Heymach Scott M. Lippman Stephen G. Swisher Bonnie S. Glisson Merrill S. Kies Heather Lin
Journals: Journal of Clinical Oncology (16 papers)Annals of Oncology (10 papers)Journal of Thoracic Oncology (7 papers)Head & Neck (7 papers)Cancer Prevention Research (6 papers)
Partner nations: United States Brazil China

In The Last Decade

William N. William

105 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint 2014 · 416 citations

Peers

Countries citing papers authored by William N. William

Since Specialization

Citations

This map shows the geographic impact of William N. William's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William N. William with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William N. William more than expected).

Fields of papers citing papers by William N. William

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William N. William. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William N. William. The network helps show where William N. William may publish in the future.

Co-authors

The 25 scholars most cited alongside William N. William, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William N. William Line = papers co-authored together William N. William links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	LiGeR-HN phase III trials of petosemtamab + pembrolizumab and petosemtamab monotherapy in recurrent or metastatic HNSCC Future Oncology ·Jean‐Pascal Machiels, Jérôme Fayette, Robert I. Haddad, Douglas R. Adkins, Maura L. Gillison, Kevin J. Harrington, Sung‐Bae Kim, Christophe Le Tourneau, Amanda Psyrri, Ari Rosenberg, Lillian L. Siu, Makoto Tahara, William N. William, Zheng Jin-zi, Tejas S Kumar, Yelena Vetlova, Yunqi Liu, David D. Yao, Fabian Zohren, Everett E. Vokes	2025	1
2	LBA54 Amivantamab plus chemotherapy vs chemotherapy in EGFR-mutated, advanced non-small cell lung cancer after disease progression on osimertinib: Second interim overall survival from MARIPOSA-2 Annals of Oncology ·Daniel Malagarriga, Erin E. Gallagher, Raffaele Califano, SH Lee, DI-YING HUANG, K. Ostner, Yuzhuo Wang, R Bhavani, 玉仪黄, N. Girard, Ryan D. Gentzler, William N. William, 佐藤正隆, Misako Nagasaka, K. J. KLEBE, Shalin Shah, B. Diorio, 康彦紺野, Juan Antonio Villanueva Hernández, Antonio Passaro	2024	6
3	Evaluating GPT-4 as an academic support tool for clinicians: a comparative analysis of case records from the literature SHILAP Revista de lepidopterología ·Bibiana Fabre, Camila Souza Carvalho Class, Pedro Nazareth Aguiar, Nur Fadilah Bakri, Cruz Valdés, William N. William, Auro del Giglio	2024	2
4	OA12.06 Intensified Chemo-Immuno-Radiotherapy with Durvalumab for Stage III NSCLCs: A Single Arm Phase II Study - PACIFIC-BRAZIL (LACOG 2218) Journal of Thoracic Oncology ·William N. William, (unknown), O. Nagwa, 전송열, Leila Yazi, 康安宅, 啓一高石, Luigi Ferrigno, Asif Muzaffar, Anand Noel C. Manohar, Inga Kirstukaitė, Nathan W. Blackburn, Vaughan Rapatahana, Young Seok Cho, Qiu Zi-hui	2024	3
5	1209MO Neoadjuvant nivolumab and nivolumab+ipilimumab in resectable non-small cell lung cancer: Combined analysis of 5-year outcomes from NEOSTAR and CA209-159 Annals of Oncology ·Joshua E. Reuss, Cheuk Hong Leung, Adelson Alexandrino, Nicolas Zhou, Nurye Seid Muhie, Apar Pataer, William N. William, Joseph H. Taube, Stephen Broderick, H. H. Beeghly, David R. Jones, Don L. Gibbons, John V. Heymach, Valsamo Anagnostou, Heather Lin, J.J. Lee, Boris Sepesi, Jamie E. Chaft, Linda Cox, Tina Cascone	2024	0
6	LBA15 Amivantamab plus chemotherapy (with or without lazertinib) vs chemotherapy in EGFR-mutated advanced NSCLC after progression on osimertinib: MARIPOSA-2, a phase III, global, randomized, controlled trial Annals of Oncology ·Antonio Passaro, Byoung Chul Cho, Yan Wang, Barbara Melosky, Raffaele Califano, SH Lee, Nicolas Girard, Karen L. Reckamp, Toshiaki Takahashi, Enriqueta Felip, Ryan D. Gentzler, Sanjay Popat, William N. William, Tao Sun, Shalin Shah, B. Diorio, Roland E. Knoblauch, Joshua Bauml, M.R. García-Campelo, Jing Wang	2023	8
7	Deep learning‐based pathology image analysis predicts cancer progression risk in patients with oral leukoplakia Cancer Medicine ·Xinyi Zhang, Frederico O. Gleber‐Netto, Shidan Wang, Pauline Farley, Ricardo Santiago Gomez, Nadarajah Vigneswaran, Judy A. Chambers, William N. William, Vassiliki A. Papadimitrakopoulou, Michelle D. Williams, Diana Bell, Doreen N. Palsgrove, Justin A. Bishop, John V. Heymach, Ann M. Gillenwater, Jeffrey N. Myers, Renata Ferrarotto, Scott M. Lippman, Curtis R. Pickering, Guanghua Xiao	2023	19
8	Current Scenario of Clinical Cancer Research in Latin America and the Caribbean Current Oncology ·สุรีพร อุทัยคุปต์, M R House, Cynthia Villarreal‐Garza, Ana S. Ferrigno, Denisse Bretel, Raúl Sala, Juliana Giacomazzi, William N. William, Gustavo Werutsky	2023	17
9	Impact of the COVID-19 Pandemic on Physicians Working in the Head and Neck Field International Archives of Otorhinolaryngology ·Rui Imamura, Ricardo Ferreira Bento, Leandro Luongo Matos, William N. William, Gustavo Nader Marta, Aline Lauda Freitas Chaves, Gilberto de Castro, Luiz Paulo Kowalski	2021	1
10	Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma Cancer Prevention Research ·V.J.C. Hunink, Taghreed Hirz, Irene Guijarro, Monique B. Nilsson, Marlese A. Pisegna, Alissa Poteete, Hampartsoum B. Barsoumian, Jared J. Fradette, Denardi Fg, Don L. Gibbons, Xiangjun Tian, Jing Wang, Jeffrey N. Myers, Mark J. McArthur, Diana Bell, William N. William, John V. Heymach	2020	25
11	Evaluation of Prexasertib, a Checkpoint Kinase 1 Inhibitor, in a Phase Ib Study of Patients with Squamous Cell Carcinoma Clinical Cancer Research ·David S. Hong, Kathleen N. Moore, Manish R. Patel, Stefan C. Grant, Howard A. Burris, William N. William, Suzanne F. Jones, Funda Meric‐Bernstam, Jeffrey R. Infante, E. C. Cropper, Wei Zhang, Ricardo Martínez, Sameera R. Wijayawardana, Richard P. Beckmann, Aimee Bence Lin, Cathy Eng, Johanna C. Bendell	2018	62
12	Evaluation of classical clinical endpoints as surrogates for overall survival in patients treated with immune checkpoint blockers: a systematic review and meta-analysis Journal of Cancer Research and Clinical Oncology ·Howard L. Kaufman, Lawrence H. Schwartz, William N. William, Mario Sznol, Kyle Fahrbach, Yingxin Xu, Eric Masson, Kendall Scott Wills	2018	23
13	PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions Cancer Prevention Research ·Jin Wang, Tongxin Xie, Bingbing Wang, William N. William, John V. Heymach, Adel K. El‐Naggar, Jeffrey N. Myers, Carlos Caulı́n	2017	58
14	Distinct pattern of TP53 mutations in human immunodeficiency virus–related head and neck squamous cell carcinoma Cancer ·Frederico O. Gleber‐Netto, Mei Zhao, Sanchit Trivedi, Jiping Wang, Samar A. Jasser, Zian Gner Alpaslan, Humam Kadara, Jiexin Zhang, Jing Wang, William N. William, J. Jack Lee, Minh Ly Nguyen, Sara I. Pai, Heather M. Walline, Dong M. Shin, Robert L. Ferris, Thomas E. Carey, Jeffrey N. Myers, Curtis R. Pickering	2017	18
15	Prevention of Tumor Growth Driven by PIK3CA and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3 Cancer Prevention Research ·N.J. Stone, Lynn Vitale‐Cross, Daniel Martı́n, Abraham Schneider, Alfredo Molinolo, Nitin Gangane, Thomas E. Carey, Jonathan B. McHugh, Christine M. Komarck, Heather M. Walline, William N. William, Raja R. Seethala, Robert L. Ferris, J. Silvio Gutkind	2015	48
16	Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease Molecular Cancer Therapeutics ·浩一加茂, Yurisha Goorun, William N. William, Ying Liu, Jie Ma, H. Sökjer, 賢司堀江, I. Secka, Li Jiang, Jeffrey N. Myers, J. Jack Lee, Sören Jahn, Zhiyuan Zhang	2013	27
17	High-Dose Fenretinide in Oral Leukoplakia Cancer Prevention Research ·William N. William, J. Jack Lee, Scott M. Lippman, Jack W. Martin, Nitin Chakravarti, Hai T. Tran, Anita L. Sabichi, Edward S. Kim, Lei Feng, Reuben Lotan, Vassiliki A. Papadimitrakopoulou	2009	33
18	Induction Chemotherapy and Cetuximab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Results From a Phase II Prospective Trial Journal of Clinical Oncology ·Merrill S. Kies, Floyd Christopher Holsinger, J. Jack Lee, William N. William, Bonnie S. Glisson, Heather Lin, Jan S. Lewin, Lawrence E. Ginsberg, Claude Roz eacute, Erminia Massarelli, Lauren A. Byers, Scott M. Lippman, Waun Ki Hong, Adel K. El‐Naggar, Adam S. Garden, Vassiliki A. Papadimitrakopoulou	2009	187
19	Cyclin D1 and Cancer Development in Laryngeal Premalignancy Patients Cancer Prevention Research ·Vassiliki A. Papadimitrakopoulou, Julie Izzo, Diane D. Liu, Jeffrey N. Myers, 錠二近田, Jan S. Lewin, William N. William, Zhong Yon, J. Jack Lee, Ann M. Gillenwater, Adel K. El‐Naggar, Xifeng Wu, Scott M. Lippman, Walter N. Hittelman, Waun Ki Hong	2009	32
20	A phase 2 study of cetuximab in combination with docetaxel in chemotherapy‐refractory/resistant patients with advanced nonsmall cell lung cancer Cancer ·Edward S. Kim, Ann M. Mauer, William N. William, Hai T. Tran, Diane Liu, J. Jack Lee, Shu Zhankun, Waun Ki Hong, Everett E. Vokes, Roy S. Herbst	2009	27

About William N. William

William N. William is a scholar working on Otorhinolaryngology, Oncology, Periodontics, Pulmonary and Respiratory Medicine and Cancer Research, having authored 109 papers that have together received 4.0k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (37 papers), Lung Cancer Treatments and Mutations (31 papers), Cancer Immunotherapy and Biomarkers (25 papers), Lung Cancer Diagnosis and Treatment (18 papers), Lung Cancer Research Studies (15 papers), Head and Neck Surgical Oncology (13 papers), Oral Health Pathology and Treatment (10 papers) and Salivary Gland Tumors Diagnosis and Treatment (10 papers). The work is most often cited by research in Otorhinolaryngology (870 citations), Oncology (2.0k citations), Pulmonary and Respiratory Medicine (1.5k citations), Periodontics (177 citations) and Cancer Research (559 citations). William N. William has collaborated with scholars based in United States, Brazil and China. Frequent co-authors include J. Jack Lee, Edward S. Kim, John V. Heymach, Scott M. Lippman, Stephen G. Swisher, Bonnie S. Glisson, Merrill S. Kies, Heather Lin, Neda Kalhor and Apar Pataer. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, Head & Neck and Cancer Prevention Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact